Debut Plus

1,049.2

-10.38 -0.98%

17 Jul 2026

NSE Listed

Strides Pharma Sci Ltd. (STAR)

Volume: 67,827Avg Vol 1W: 1,66,400.6Avg Vol 1M: 1,52,955.252W Range:768.651,231
Market Cap₹9,767 Cr
Current Price₹1,049.2
Previous Close₹1,059.58
High / Low (52w)₹1,231 / ₹768.65
Volume67,827
Avg Vol (1W)1,66,400.6
Avg Vol (1M)1,52,955.2
Stock P/E76.95
Book Value₹337.15
Dividend Yield47%
ROE17.9%
ROA8.29%
Revenue (TTM)₹4,624 Cr
Revenue Growth17.4%
Profit Margin11.45%
Total Debt₹571 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹62.84
P/B3.15
Debt / Equity0.94
50 DMA₹1,099.27
200 DMA₹958.39
Day change-0.98%
Price Chart
1,049.2 14.31% · 1Y
118879492.2L
2025-07-16
2026-07-15

20-day avg volume: 1.5L shares

Pros
  • Healthy return on equity of 17.9%.
  • Pays a dividend yield of 47.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 17% YoY.
  • Stock trades at a high P/E of 77.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,054 Cr₹1,167 Cr₹1,154 Cr₹1,190 Cr₹1,120 Cr₹1,221 Cr₹1,195 Cr₹1,323 Cr
EBITDA₹156 Cr₹165 Cr₹168 Cr₹181 Cr₹178 Cr₹209 Cr₹292 Cr₹195 Cr
Net Profit₹3,351 Cr₹72 Cr₹88 Cr₹82 Cr₹100 Cr₹128 Cr₹202 Cr₹127 Cr
EPS
Profit & Loss (Annual)
MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2025
Revenue₹3,278 Cr₹2,917 Cr₹2,921 Cr₹2,219 Cr₹2,805 Cr₹3,367 Cr₹3,202 Cr₹4,624 Cr
EBITDA₹485 Cr₹562 Cr₹337 Cr₹166 Cr₹395 Cr₹480 Cr₹-121 Cr₹669 Cr
Net Profit₹209 Cr₹400 Cr₹665 Cr₹325 Cr₹36 Cr₹268 Cr₹-460 Cr₹3,593 Cr
EPS25.1444.6474.2336.244.0629.92-51.28390.5
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹6,708 Cr₹7,980 Cr₹6,152 Cr₹7,015 Cr₹6,976 Cr₹6,049 Cr
Total Liabilities₹4,090 Cr₹5,178 Cr₹3,557 Cr₹4,201 Cr₹4,593 Cr₹3,462 Cr
Equity₹2,618 Cr₹2,802 Cr₹2,595 Cr₹2,814 Cr₹2,383 Cr₹2,586 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹241 Cr₹116 Cr₹250 Cr₹325 Cr₹-260 Cr₹-43 Cr₹677 Cr₹617 Cr
Investing₹583 Cr₹-148 Cr₹1,306 Cr₹-521 Cr₹-119 Cr₹302 Cr₹-150 Cr₹-90 Cr
Financing₹-1,016 Cr₹194 Cr₹-1,709 Cr₹-16 Cr₹421 Cr₹-214 Cr₹-693 Cr₹-643 Cr
Free Cash Flow₹241 Cr₹116 Cr₹100 Cr₹27 Cr₹-404 Cr₹-138 Cr₹559 Cr₹375 Cr
Shareholding
Promoter 27.91% Institutions 43.13% Public 28.96%
Efficiency & Working Capital
ROCE17.3%
Interest Coverage2.7
Dividend Payout
Debtor Days96 d
Inventory Days102 d
Payable Days83 d
Cash Conversion Cycle116 d
Working Capital Days198 d
Shareholding Details

As of 2026-03-31

Promoter27.9%
FII28.7%
DII14.4%
Institutions43.1%
Public29%
Promoter Pledge27.3%
No. of Shareholders86,616
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters28.1%27.8%27.4%25.9%25.9%25.8%26.8%28.3%28.3%27.9%27.9%27.9%
FIIs16.7%17.2%19.4%24.6%26.7%30.1%28.5%28.3%28%28.5%29.5%28.7%
DIIs20%18.2%17.6%18%18.6%18.2%16.9%13.7%13.3%13%13%14.4%
Public35.2%36.8%35.6%31.5%28.9%25.8%27.8%29.7%30.4%30.6%29.6%29%
Promoter Pledge80.8%67.4%69.2%72.7%64.7%49.2%54.3%52%50.1%44.1%30.6%27.3%
No. of Shareholders1,12,7751,01,63891,18284,69591,91796,0091,14,23695,12592,88991,20685,58986,616
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Pronomz Ventures LlpShareholding of Promoter and Promoter Group19.6%1.81 Cr
Quant Mutual Fund - Quant Multi Cap FundPublic Shareholding5.4%49,77,936
Route One Offshore Master Fund, L.p.Public Shareholding5.1%46,53,310
Sbi Life Insurance Co. LtdPublic Shareholding4.3%39,12,939
Karuna Business Solutions LlpShareholding of Promoter and Promoter Group3.5%32,25,050
Route One Fund I, L.p.Public Shareholding2.2%19,97,344
Arun Kumar PillaiShareholding of Promoter and Promoter Group2%18,60,687
Bandhan Nifty Total Market Index FundPublic Shareholding1.7%15,33,468
Satpal KhattarPublic Shareholding1.6%14,74,942
K R RavishankarShareholding of Promoter and Promoter Group1.4%12,55,593
Abu Dhabi Investment Authority - MonsoonPublic Shareholding1.3%12,25,663
Authum Investment And Infrastructure LimitedPublic Shareholding1.3%11,95,126
Mukul Mahavir AgrawalPublic Shareholding1.2%10,66,000
Ishares Core Msci Emerging Markets EtfPublic Shareholding1.1%10,31,539
Oman India Joint Investment Fund IiPublic Shareholding1.1%10,11,103
Agraganya Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd)Shareholding of Promoter and Promoter Group0.3%3,00,000
Karuna Family Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd)Shareholding of Promoter and Promoter Group0.2%2,10,000
Vineetha Mohanakumar PillaiShareholding of Promoter and Promoter Group0.2%1,90,000
Padmakumar Karunakaran PillaiShareholding of Promoter and Promoter Group0.2%1,86,485
K R LakshmiShareholding of Promoter and Promoter Group0.1%1,30,482
Sajitha PillaiShareholding of Promoter and Promoter Group0.1%95,000
Rajitha GopalakrishnanShareholding of Promoter and Promoter Group0.1%60,000
Hemalatha PillaiShareholding of Promoter and Promoter Group0.1%66,760
Aditya Arun KumarShareholding of Promoter and Promoter Group0.1%58,422
Anuradha K RShareholding of Promoter and Promoter Group0%5,470
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sajitha Pillai00%2026-03-31
K R Lakshmi00%2026-03-31
K R Ravishankar00%2026-03-31
Rajitha Gopalakrishnan00%2026-03-31
Padmakumar Karunakaran Pillai00%2026-03-31
Anuradha K R00%2026-03-31
Vineetha Mohanakumar Pillai00%2026-03-31
Arun Kumar Pillai00%2026-03-31
Hemalatha Pillai00%2026-03-31
Aditya Arun Kumar00%2026-03-31
Deepa Arun Kumar00%2026-03-31
Rajeswari Amma00%2026-03-31
Board of Directors
NameDesignationYear
Arun KumarChairman & Non Executive Dir.2025
Badree KomandurExecutive Director / WTD / Managing Director / CEO2025
Kausalya SanthanamIndependent Non Exe. Director2025
Mukta Malik AroraIndependent Non Exe. Director2025
Homi R KhusrokhanIndependent Non Exe. Director2025
Ameet HarianiIndependent Non Exe. Director2025
Subir ChakrabortyIndependent Non Exe. Director2025
Aditya KumarNon Executive Director2025
Manjula RamamurthyCompany Sec. & Compli. Officer2025
VENKATA SEETHARAMA RAJU PAKALAPATIExecutive Director2025
Segments — Product
SegmentRevenueShare
Pharmaceutical business₹2,153 Cr100%
Bio-pharmaceutical business₹0 Cr0%
Segments — Geography
RegionRevenueShare
North America₹21 Cr1%
Australia₹67 Cr3.3%
Africa₹3 Cr0.1%
Europe₹479 Cr23.4%
India₹18 Cr0.9%
Asia₹1,456 Cr71%
Others₹6 Cr0.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹102189292
Corporate Actions
TypeDateValueRemark
dividend2025-07-22₹4 (40%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20251,945240243112,305
202530021420
202513124022278455
Insider / Designated-Person Trades

16 recent disclosure(s)

PRONOMZ VENTURES LLPAcquisition · 45,450
PRONOMZ VENTURES LLPAcquisition · 53,200
AGRAGANYA PRIVATE TRUSTAcquisition · 3,00,000
PRONOMZ VENTURES LLPAcquisition · 2,91,250
PRONOMZ VENTURES LLPAcquisition · 52,000
Karuna Business Solutions LLPAcquisition · 1,550
Substantial Acquisitions (SAST)

2 disclosure(s)

Release Of Pledge18/03/2024 ·
Pledge09/10/2023 ·
Company Information
Incorporated1990
ChairmanArun Kumar
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.strides.com

📍 No 201 Devavrata Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search